At present, the company is building an HPV vaccine production facility in Taizhou, Jiangsu Province, with an annual production potential of up to 20 million doses of HPV nine-valent vaccine in the first phase. The Company's new manufacturing facility is designed and built to produce vaccines in compliance, which meets the WHO Prequalification (WHO PQ) Standards with full production capacity and ready for commercial production.

The production base covers a total area of 122.92 mu, with a total construction area of 103,068.80 m2. The main construction contents include HPV vaccine building, comprehensive warehouse, quality inspection and development building, animal room, power center and other newly built production plants. Through the purchase of fermentation equipment, purification equipment, pre-potting production line and other production equipment, the project adopts fermentation, purification, preparation and other production technologies to build a number of stock liquid production lines and potting production lines.

HPV Vaccine Manufacturing Facility Address: No.888, Yaocheng Avenue, China Medical City, Taizhou City.